The University of Southampton
University of Southampton Institutional Repository

Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study

Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study
Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study
Aims: whether the plasma-based ceramide-based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain.

Materials and methods: baseline and follow-up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54–79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0). Based on the CERT1 risk score, patients were split into four risk categories (low, moderate, increased or high risk). The primary outcome was a composite of overall mortality and incident nonfatal CVD outcomes (including myocardial infarction, ischaemic stroke or permanent atrial fibrillation).

Results: one hundred and thirty-nine patients developed the primary composite outcome (72 nonfatal CVD outcomes and 67 total deaths) during follow-up. Baseline CERT1 risk categories were significantly associated with the risk of developing the primary composite outcome (adjusted HR for high vs. low-risk category 2.43, 95% CI 1.39–4.22, p = 0.002, and adjusted HR for increased vs. low-risk category 2.16, 95% CI 1.28–3.63, p = 0.004). Receiver operator characteristic curve analysis showed that adding CERT1 risk score to traditional CVD risk factors and pre-existing CVD, improved the discriminatory capability of the regression model for predicting the primary composite outcome (AUROC 0.691 [95% CI 0.674–0.769] vs. 0.722 [95% CI 0.642–0.742], p = 0.0275).

Conclusions the ceramide-based risk score CERT1 risk score improves risk prediction for long-term risk of overall mortality and adverse cardiovascular outcomes in patients with and without CVD.
CERT1 score, CVD, cardiovascular morbidity, mortality, plasma ceramides
1462-8902
1488-1497
Mantovani, Alessandro
14094518-4dce-4b10-91af-8fa4e362e987
Lunardi, Gianluigi
50f8731b-769b-47a8-aa67-311b47fd708c
Bonapace, Stefano
8510ed9a-bcb9-4c2b-8c4c-7a4181c0e28d
Molinero, Agustin E.
0ac25baf-b8f8-4992-8072-0f5ce5f2f4d0
Morandin, Riccardo
9a4802e6-c8a8-43de-a18a-52227094db89
Fiorio, Veronica
da165672-fa18-42da-bde4-387026568ea6
Molon, Giulio
3533be73-8d90-4ac3-9d95-4ece41678d29
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
404b0f39-7235-42b3-a296-6ef8fb4c9d3a
Mantovani, Alessandro
14094518-4dce-4b10-91af-8fa4e362e987
Lunardi, Gianluigi
50f8731b-769b-47a8-aa67-311b47fd708c
Bonapace, Stefano
8510ed9a-bcb9-4c2b-8c4c-7a4181c0e28d
Molinero, Agustin E.
0ac25baf-b8f8-4992-8072-0f5ce5f2f4d0
Morandin, Riccardo
9a4802e6-c8a8-43de-a18a-52227094db89
Fiorio, Veronica
da165672-fa18-42da-bde4-387026568ea6
Molon, Giulio
3533be73-8d90-4ac3-9d95-4ece41678d29
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Targher, Giovanni
404b0f39-7235-42b3-a296-6ef8fb4c9d3a

Mantovani, Alessandro, Lunardi, Gianluigi, Bonapace, Stefano, Molinero, Agustin E., Morandin, Riccardo, Fiorio, Veronica, Molon, Giulio, Byrne, Chrisopher D. and Targher, Giovanni (2025) Ceramide-based risk score CERT-1 improves risk prediction for overall mortality and adverse cardiovascular outcomes in patients with and without cardiovascular disease: a prospective cohort study. Diabetes, Obesity and Metabolism, 27 (3), 1488-1497. (doi:10.1111/dom.16156).

Record type: Article

Abstract

Aims: whether the plasma-based ceramide-based risk score CERT1 improves risk prediction for cardiovascular disease (CVD) is uncertain.

Materials and methods: baseline and follow-up data were combined from two cohorts, 334 patients with established/suspected CVD and 196 patients with type 2 diabetes followed for a median of 74 months (interquartile range 54–79 months). For the calculation of CERT1 risk score, we measured four specific plasma ceramides [Cer(d18:1/16:0), Cer(d18:1/18:0) and Cer(d18:1/24:1)] and their ratios to Cer(d18:1/24:0). Based on the CERT1 risk score, patients were split into four risk categories (low, moderate, increased or high risk). The primary outcome was a composite of overall mortality and incident nonfatal CVD outcomes (including myocardial infarction, ischaemic stroke or permanent atrial fibrillation).

Results: one hundred and thirty-nine patients developed the primary composite outcome (72 nonfatal CVD outcomes and 67 total deaths) during follow-up. Baseline CERT1 risk categories were significantly associated with the risk of developing the primary composite outcome (adjusted HR for high vs. low-risk category 2.43, 95% CI 1.39–4.22, p = 0.002, and adjusted HR for increased vs. low-risk category 2.16, 95% CI 1.28–3.63, p = 0.004). Receiver operator characteristic curve analysis showed that adding CERT1 risk score to traditional CVD risk factors and pre-existing CVD, improved the discriminatory capability of the regression model for predicting the primary composite outcome (AUROC 0.691 [95% CI 0.674–0.769] vs. 0.722 [95% CI 0.642–0.742], p = 0.0275).

Conclusions the ceramide-based risk score CERT1 risk score improves risk prediction for long-term risk of overall mortality and adverse cardiovascular outcomes in patients with and without CVD.

Text
cert1 score and outcomes_R1_clean copy - Accepted Manuscript
Download (110kB)
Text
Figure 1 - Accepted Manuscript
Download (25kB)
Text
Figure 2 - Accepted Manuscript
Download (39kB)
Text
Figure 3 - Accepted Manuscript
Restricted to Repository staff only until 14 December 2025.
Request a copy
Text
Online-only Supplementary Material_R1 - Accepted Manuscript
Restricted to Repository staff only until 14 December 2025.
Request a copy
Text
Diabetes Obesity Metabolism - 2024 - Mantovani - Ceramide‐based risk score CERT‐1 improves risk prediction for overall - Version of Record
Download (1MB)

Show all 6 downloads.

More information

Accepted/In Press date: 14 December 2024
e-pub ahead of print date: 26 December 2024
Published date: 1 March 2025
Keywords: CERT1 score, CVD, cardiovascular morbidity, mortality, plasma ceramides

Identifiers

Local EPrints ID: 497341
URI: http://eprints.soton.ac.uk/id/eprint/497341
ISSN: 1462-8902
PURE UUID: 0ce1890c-c87c-4cc2-b605-e989edd6a6e0
ORCID for Chrisopher D. Byrne: ORCID iD orcid.org/0000-0001-6322-7753

Catalogue record

Date deposited: 20 Jan 2025 17:53
Last modified: 22 Aug 2025 01:45

Export record

Altmetrics

Contributors

Author: Alessandro Mantovani
Author: Gianluigi Lunardi
Author: Stefano Bonapace
Author: Agustin E. Molinero
Author: Riccardo Morandin
Author: Veronica Fiorio
Author: Giulio Molon
Author: Giovanni Targher

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×